Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lung Neoplasms × DNA × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Teratoma, Ovarian 1 Struma Ovarii 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Metabolic Syndrome 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Disease 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 21 Blood Specimen Collection 21 Gene Expression Profiling 12 Radiotherapy 11 Magnetic Resonance Spectroscopy 9 Immunohistochemistry 9 Drug Therapy 9 Surgical Procedures, Operative 8 Specimen Handling 8 Polymerase Chain Reaction 7 Bronchoscopy 7 Amplified Fragment Length Polymorphism Analysis 7 pembrolizumab 6 Psychiatric Rehabilitation 6 Observation 6 Interviews as Topic 6 Carboplatin 6 Tomography, X-Ray Computed 5 Thoracic Surgery, Video-Assisted 5 Reverse Transcriptase Polymerase Chain Reaction 5 Liquid Biopsy 5 durvalumab 4 Therapeutics 4 Paclitaxel 4 Microarray Analysis 4 Ipilimumab 4 Immunotherapy 4 Biopsy 4 Bevacizumab 4 osimertinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04215913 2020-01-02

PSC

Shanghai 10th People's Hospital

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡